LMR Partners’s Disc Medicine IRON Stock Holding History

LMR Partners’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-758	Closed	-$308K	–	1223
2021 Q1	$308K	Buy	+758	New	+$338K	0.01%	725

Other funds holding IRON

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

LMR Partners's IRON Position: Q2 2021 in Review

LMR Partners sold out of Disc Medicine (IRON) in Q2 2021, closing a stake of 758 shares — an estimated $308K sold.

LMR Partners first reported a position in IRON in Q1 2021 and held it in 1 quarter. The position peaked at $308K in Q1 2021. 55 funds tracked by Wall St. Rank hold IRON as of Q2 2021.

LMR Partners reported no remaining Disc Medicine position as of Q2 2021 after selling out during the quarter.
LMR Partners sold 758 Disc Medicine shares in Q2 2021, an estimated $308K.
LMR Partners first reported a position in Disc Medicine in Q1 2021 and held it in 1 quarter.
LMR Partners's Disc Medicine position peaked at $308K in Q1 2021.
55 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2021.

Based on LMR Partners's 13F filing for Q2 2021, filed 16 Aug 2021.